FDA OKs product for aiding in cataract surgery:
This article was originally published in Clinica
The US FDA has approved for the first time a product for staining the anterior lens capsule during cataract surgery. Vision Blue (trypan blue ophthalmic solution), made by Dutch firm DORC International, enhances the ability of ophthalmologists to remove white cataracts - very advanced mature cataracts - by allowing the capsule to be observed as it is cut and removed. Clean cuts in the capsule are known to reduce some of the risks associated with the surgical removal of a cataract, said the FDA. The agency noted that of the 1.4 million people that undergo cataract surgery each year in the US, mature white cataracts account for only a small portion. Vision Blue is currently marketed in 30 countries.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.